Back to Results
First PageMeta Content
Acute myeloid leukemia / Myeloid leukemia / MG Cars / Decitabine / Hypomethylating agent / Oncology / Medicine / Acute leukemia


Comparison of the Efficacy and Safety of 5-day and 10day schedules of SGI-110, a novel subcutaneous (SC) hypomethylating agent (HMA), in the treatment of relapsed/refractory Acute Myeloid Leukemia (r/r AML) Gail J. Roboz
Add to Reading List

Open Document

File Size: 824,20 KB

Share Result on Facebook
UPDATE